HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$1.58
-0.05 (-3.07%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,110.1% upside
Low Target
$13.94
Average Target
$19.12
High Target
$23.15
Current Price
$1.58
Current
$1.58
$1.58
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Scenario Analysis
Bear Case
$13.94
782.3%
Low target
Base Case
$19.12
+1,110.1%
Avg target
Bull Case
$23.15
+1,365.2%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$6.19
-74.5% from high
52-Week Low
$1.61
+-1.9% from low
Target vs 52W High
$19.12
+208.9% vs high
Next Earnings Report
Nov 24, 2026
16d
until earnings
EPS Est: $-0.21
Peer Consensus — Pharmaceuticals